128 related articles for article (PubMed ID: 24689504)
1. Febrile pleuropericarditis, a potentially life-threatening adverse event of balsalazide--case report and literature review of the side effects of 5-aminosalicylates.
Coman RM; Glover SC; Gjymishka A
Expert Rev Clin Immunol; 2014 May; 10(5):667-75. PubMed ID: 24689504
[TBL] [Abstract][Full Text] [Related]
2. 5-ASA induced recurrent myopericarditis and cardiac tamponade in a patient with ulcerative colitis.
Sonu I; Wong R; Rothenberg ME
Dig Dis Sci; 2013 Aug; 58(8):2148-50. PubMed ID: 23361575
[No Abstract] [Full Text] [Related]
3. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
Pruitt R; Hanson J; Safdi M; Wruble L; Hardi R; Johanson J; Koval G; Riff D; Winston B; Cross A; Doty P; Johnson LK
Am J Gastroenterol; 2002 Dec; 97(12):3078-86. PubMed ID: 12492193
[TBL] [Abstract][Full Text] [Related]
4. Balsalazide: a novel 5-aminosalicylate prodrug for the treatment of active ulcerative colitis.
Wiggins JB; Rajapakse R
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1279-84. PubMed ID: 19743890
[TBL] [Abstract][Full Text] [Related]
5. Comparison of mesalazine and balsalazide in induction and maintenance of remission in patients with ulcerative colitis: a meta-analysis.
Rahimi R; Nikfar S; Rezaie A; Abdollahi M
Dig Dis Sci; 2009 Apr; 54(4):712-21. PubMed ID: 18683049
[TBL] [Abstract][Full Text] [Related]
6. Ulcerative colitis treatment for children and teens.
FDA Consum; 2007; 41(2):5. PubMed ID: 17582854
[No Abstract] [Full Text] [Related]
7. Balsalazide in treating colonic diseases.
Tursi A
Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1555-63. PubMed ID: 19708827
[TBL] [Abstract][Full Text] [Related]
8. Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. The Abacus Investigator Group.
Green JR; Lobo AJ; Holdsworth CD; Leicester RJ; Gibson JA; Kerr GD; Hodgson HJ; Parkins KJ; Taylor MD
Gastroenterology; 1998 Jan; 114(1):15-22. PubMed ID: 9428213
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK
Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857
[TBL] [Abstract][Full Text] [Related]
10. Mesalazine-induced myopericarditis in a patient with ulcerative colitis.
Doganay L; Akinci B; Pekel N; Simsek I; Akpinar H
Int J Colorectal Dis; 2006 Mar; 21(2):199-200. PubMed ID: 15726390
[No Abstract] [Full Text] [Related]
11. Balsalazide disodium for the treatment of ulcerative colitis.
Patil SA; Moss AC
Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):177-84. PubMed ID: 19072352
[TBL] [Abstract][Full Text] [Related]
12. [Mesalazine-induced acute pericarditis].
Sierra Ausín M; Rascarachi G; Díez Rodríguez R; Arias Rodríguez L; Del Pozo Maroto E; Muñoz Núñez F
Gastroenterol Hepatol; 2010 Apr; 33(4):338-9. PubMed ID: 20005014
[No Abstract] [Full Text] [Related]
13. The efficacy of oral 5-ASAs in the treatment of active ulcerative colitis: a systematic review.
Kane SV; Bjorkman DJ
Rev Gastroenterol Disord; 2003; 3(4):210-8. PubMed ID: 14668693
[TBL] [Abstract][Full Text] [Related]
14. Acute pericarditis associated with 5-aminosalicylic acid (5-ASA) treatment for severe active ulcerative colitis.
Ishikawa N; Imamura T; Nakajima K; Yamaga J; Yuchi H; Ootsuka M; Inatsu H; Aoki T; Eto T
Intern Med; 2001 Sep; 40(9):901-4. PubMed ID: 11579953
[TBL] [Abstract][Full Text] [Related]
15. Recurrent pericarditis due to mesalamine hypersensitivity: a pediatric case report and review of the literature.
Sentongo TA; Piccoli DA
J Pediatr Gastroenterol Nutr; 1998 Sep; 27(3):344-7. PubMed ID: 9740210
[No Abstract] [Full Text] [Related]
16. Mesalamine-induced myopericarditis - A case report.
Bernardo S; Fernandes SR; Araújo-Correia L
Rev Esp Enferm Dig; 2016 Nov; 108(11):753-756. PubMed ID: 26876057
[TBL] [Abstract][Full Text] [Related]
17. Pleuropericarditis in a patient with ulcerative colitis in longstanding 5-aminosalicylic acid therapy.
Iaquinto G; Sorrentini I; Petillo FE; Berardesca G
Ital J Gastroenterol; 1994 Apr; 26(3):145-7. PubMed ID: 8061342
[TBL] [Abstract][Full Text] [Related]
18. Myopericarditis and mitral insufficiency associated with ulcerative colitis treated with mesalazine.
García-Morán S; Sáez-Royuela F; Pérez-Alvarez JC; Gento E; Téllez J
Inflamm Bowel Dis; 2006 Apr; 12(4):334-5. PubMed ID: 16633055
[No Abstract] [Full Text] [Related]
19. Balsalazide-induced myocarditis.
Robertson E; Austin D; Jamieson N; Hogg KJ
Int J Cardiol; 2008 Nov; 130(3):e121-2. PubMed ID: 17889383
[TBL] [Abstract][Full Text] [Related]
20. Modern use of 5-aminosalicylic acid compounds for ulcerative colitis.
Le Berre C; Roda G; Nedeljkovic Protic M; Danese S; Peyrin-Biroulet L
Expert Opin Biol Ther; 2020 Apr; 20(4):363-378. PubMed ID: 31498003
[No Abstract] [Full Text] [Related]
[Next] [New Search]
